Health outcomes variables important to patients in the treatment of erectile dysfunction

The Journal of Urology
C Hanson-DiversR C Rosen

Abstract

Erectile dysfunction is underreported and the rate of noncompliance with therapy is high. The National Institutes of Health Consensus Conference on Impotence endorsed the need for outcomes research of the various approaches to treatment. The purpose of our exploratory study was to begin that process through identification of erectile dysfunction treatment outcomes variables that are important to men. The study format consisted of focus group meetings. The goal of the discussions was to identify variables that are important to men when choosing among and judging the success of treatment modalities for erectile dysfunction. After discussion participants were individually asked to identify the 10 variables that they considered important and rank the 5 most important variables. An importance score reflecting group consensus was calculated for each variable. Success and negative outcomes were identified as the 2 most important outcomes variables for all treatment modalities. Participants defined success in several ways. The most important measures of success were cure, pleasure and partner satisfaction. Negative outcome was defined as negative consequences associated with treatment. The focus group discussion assisted in identifying...Continue Reading

References

Dec 14, 1989·The New England Journal of Medicine·R J KraneI Saenz de Tejada
Jan 1, 1985·Bone·J MangarooA S Kapadia
May 1, 1994·Journal of Clinical Epidemiology·H A FeldmanJ B McKinlay
Feb 1, 1995·The American Journal of the Medical Sciences·M A AlpertM C Culpepper
Feb 1, 1995·The American Journal of the Medical Sciences·T M ShinnickF D Quinn
Oct 1, 1994·Journal of Psychosomatic Research·N P BuchholzW Langewitz
Aug 1, 1993·Australian Family Physician·G S Reisner
Sep 1, 2005·The National Medical Journal of India·J Chandra SinghK Ninan Chacko

❮ Previous
Next ❯

Citations

Feb 15, 2005·Urology·Culley CarsonUNKNOWN Trial Evaluating the Activity of Tadalafil for Erectile Dysfunction-United States (TREATED-US) Study Group
Dec 31, 2010·International Journal of Impotence Research·A Martin MoralesC Turbi
Aug 12, 2005·International Journal of Impotence Research·B-P JiannJ-Y Tsai
Feb 9, 2007·International Journal of Impotence Research·C M KimUNKNOWN Korea Post-Marketing Surveillance Research Group
Aug 25, 2007·International Journal of Impotence Research·M M BernerM Burkart
Dec 14, 2007·International Journal of Impotence Research·H PimentelC Niederberger
Jan 26, 2005·Journal of the American Geriatrics Society·Allen D Seftel
Jun 20, 2006·International Journal of Clinical Practice·P J Wright
Jul 25, 2009·International Journal of Clinical Practice·R SadovskyS Sorsaburu
Sep 18, 2012·BMC Complementary and Alternative Medicine·Gaurang R ShahNavneet A Sonawane
Dec 1, 2007·Clinical Interventions in Aging·Giovanni Vanni FrajeseGaetano Frajese
Sep 22, 2010·Drug Design, Development and Therapy·Samuel L Washington, Alan W Shindel
Feb 23, 1999·Postgraduate Medicine·G H Jordan
Jan 12, 2016·Expert Opinion on Drug Safety·Eugenio VentimigliaAndrea Salonia
Jul 5, 2005·Expert Opinion on Investigational Drugs·M A KhanD P Mikhailidis
May 1, 2013·Sexual Medicine Reviews·Maarten AlbersenTrinity J Bivalacqua
Jan 14, 2016·Current Opinion in Urology·M Ayodhia SoebadiMaarten Albersen
Jan 20, 2007·The Journal of Sexual Medicine·Harin Padma-Nathan For The North American And European Vardenafil Study Group
Jun 19, 2008·The Journal of Sexual Medicine·Hartmut PorstSuzanne R Klise
May 15, 2007·Fertility and Sterility·J C Trussell, Richard S Legro
Nov 17, 2004·Journal of the American Academy of Nurse Practitioners·Jean H Lewis
Feb 23, 2008·Diabetic Medicine : a Journal of the British Diabetic Association·D HatzichristouS Liang
Jul 23, 2013·International Journal of Clinical Practice·W B SmithW J Hellstrom
Aug 27, 2010·Journal of Evaluation in Clinical Practice·Joseph C Cappelleri, Vera J Stecher
Jun 18, 2010·BJU International·Ferdinando FuscoVincenzo Mirone
Apr 10, 2004·Urology·Francesco Montorsi, Stanley E Althof

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.